Life Sciences

Building Compliant Software for Clinical Research

In life sciences, compliance is not a feature you bolt on at the end. Here is how to build software for regulated research with GxP and 21 CFR Part 11 baked in from day one.

Ravi DangarFounder & Full-Stack Engineer July 30, 2026 7 min read

Software that touches clinical or research data lives under a different standard than a typical web app. Regulators do not just care whether it works — they care whether you can prove it works, prove who changed what, and prove it stayed under control. Retrofitting that proof is painful; designing for it is not.

The non-negotiables

  • Audit trails on every record: who, what, when, and the previous value.
  • Electronic signatures that are attributable and tamper-evident (21 CFR Part 11).
  • Role-based access with least privilege and periodic access review.
  • Validated environments — you document that the system does what it should.

Validation is a process, not a phase

GxP validation (IQ/OQ/PQ) is far easier when requirements are traceable to tests from the start. Keep a living requirements-to-test matrix, automate the test suite, and treat every change as something that must be re-qualified. The discipline that regulators demand is, conveniently, the same discipline that keeps complex software maintainable.

In regulated software, "it works" is not enough — you have to be able to demonstrate, on demand, that it has always worked.

Design for the auditor

Assume an auditor will one day ask to reconstruct the exact history of a single data point. If your architecture makes that a one-query answer, you have built it right. If it makes that a forensic project, you have built technical and regulatory debt at the same time.

#Life Sciences#Compliance#GxP
Explore our Life Sciences software work Back to all articles
Keep Reading

Related Articles

More practical notes from our engineering team.

Let's Build Something Worth Writing About

Tell us about your project and we'll help you turn it into a shipped product.